IC
CTKB icon

IEQ Capital’s Cytek Biosciences CTKB Stock Holding History

IEQ Capital’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399K Sell
90,100
-54,292
-38% -$232K ﹤0.01% 1509
2026
Q1 		$631K Buy
144,392
+20,401
+16% +$96.3K ﹤0.01% 1207
2025
Q4 		$626K Sell
123,991
-28,832
-19% -$134K ﹤0.01% 1229
2025
Q3 		$530K Buy
152,823
+14,062
+10% +$52.8K ﹤0.01% 1263
2025
Q2 		$472K Buy
138,761
+81,079
+141% +$270K ﹤0.01% 1189
2025
Q1 		$231K Buy
+57,682
New +$299K ﹤0.01% 1304

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IEQ Capital's CTKB Position: Q2 2026 in Review

IEQ Capital reduced its Cytek Biosciences (CTKB) stake by 38% in Q2 2026, selling an estimated $232K and leaving 90,100 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

IEQ Capital first reported a position in CTKB in Q1 2025 and has held it in 6 quarters since. The position peaked at $631K in Q1 2026. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • IEQ Capital held 90,100 shares of Cytek Biosciences worth $399K as of Q2 2026.
  • IEQ Capital sold 54,292 Cytek Biosciences shares in Q2 2026, an estimated $232K.
  • Cytek Biosciences made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1509 holding.
  • IEQ Capital first reported a position in Cytek Biosciences in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Cytek Biosciences position peaked at $631K in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.